downloads search feedback sitemap intranet webmail home
 

 
Home->ACME Laboratories->News (Press Release)

 

ACME Press Release (09-05-2007)

 

New Introduction
 

  has recently launched an antifibrinolytic agent Tranexamic Acid as TRACID tablet and injection IV says a press release.

TRACID is a 500mg film-coated tablet and 500mg/ 5ml ampoule injection IV. It is used for preventing wide range of haemorrhagic conditions, i.e. control acute upper GI bleeding, surgery (cardiopulmonary bypass, oral surgery, Orthopaedic surgery, Urinary tract surgery) Gynaecology (Menorrhagia, Consiation of Cervix, obstetrical complication, abruption placenta, post partum haemorrhage).

TRACID reduces blood loss & blood transfusion requirements. Each box contains 30 tablets and each box contains 3 ampoules. Price Tk. 15.00 tablet, Tk. 50.00 ampoule.

 


For More Information Contact:
Product Management Department
Court de la ACME
The ACME Laboratories Ltd.
Dhaka, Bangladesh.